Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG
Authors:
- Laurence DolboisLDLaurence Dolbois
- Nicolas BorotNBNicolas Borot
- Pierre PontarottiPierre Pontarotti
- Michel ClanetMCMichel Clanet
- Hélène CoppinHCHélène Coppin
- 1 September 1995
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 61 (2) , 117-122
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Two-Locus Linkage Analysis in Multiple Sclerosis (MS)Genomics, 1994
- Lack of association between myelin basic protein gene microsatellite and multiple sclerosisThe Lancet, 1993
- Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein geneThe Lancet, 1993
- A population‐based study of multiple sclerosis in twins: UpdateAnnals of Neurology, 1993
- Genetic susceptibility to multiple sclerosis linked to myelin basic protein geneThe Lancet, 1992
- DNA length polymorphism 5′ to the myelin basic protein gene is associated with multiple sclerosisAnnals of Neurology, 1990
- Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturationJournal of Neuroimmunology, 1989
- Multiple sclerosis. Updated risks for relativesAmerican Journal of Medical Genetics, 1988
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983